Posted Nov. 29, 2011 at 6:46 a.m.

Premium Lock BioDelivery Sciences scores victory in patent dispute

Published: 2011-11-29 06:46:17
Updated: 2011-11-29 06:46:17

BDSI BDSI

The US Patent and Trademark Office has rejected all 191 claims made by New Jersey-based MonoSol Rx as unpatentable. The dispute centers on the technology that forms BDSI's drug delivery platform....

Read More
Read More

Copyright 2014 MedCity. All rights reserved.
Editor's Blog

Editor's Blog

The latest blog posts from our WRAL TechWire and WRAL editors. Read more articles…

Please Log In to add a comment.

Best of TechWire Insider

Techwire Inside Partners

OUR INSIDERS

Frank Vinluan
Life science
Vivek Wadhwa
Commentary
Dr. Mike Walden
Tech economy
Scroll